1.

Emerging fields of probiotic and prebiotic use

Within the Chapter of the scientific mongraphy, we exposed some of our recent scientific achiewements together with the overview of the use of recombinant probiotics for the treatment of Crohn's disease, ulcerose colitis as well as other chronic bowel diseases connected with the change in the composition of intestinal flora.

COBISS.SI-ID: 27837991

2.

Engineering BmpA as a carrier for surface display of IgG-binding domain on Lactococcus lactis

By means oc covalent surface display, several BmpA binding protein variants were engineered and expressed. he most active constructs were able to increase the binding capacity to more than tree fold.

COBISS.SI-ID: 3318152

3.

Modified food grade microorganism for treatment of inflammatory bowel disease

The US Patent office granted the US Patent for the development of a platform enables the R&D of safe recombinant microorganisms in the treatment of inflammatory bowel disease

COBISS.SI-ID: 27820583